158 related articles for article (PubMed ID: 23225986)
41. Classification, diagnosis, and interventional radiologic management of vascular malformations.
Legiehn GM; Heran MK
Orthop Clin North Am; 2006 Jul; 37(3):435-74, vii-viii. PubMed ID: 16846771
[TBL] [Abstract][Full Text] [Related]
42. Sclerotherapy for low-flow vascular malformations of the head and neck: A systematic review of sclerosing agents.
Horbach SE; Lokhorst MM; Saeed P; de Goüyon Matignon de Pontouraude CM; Rothová A; van der Horst CM
J Plast Reconstr Aesthet Surg; 2016 Mar; 69(3):295-304. PubMed ID: 26723834
[TBL] [Abstract][Full Text] [Related]
43. Scattered Musculoskeletal Venous Malformations in Children: A Rare Report on Clinical Evaluation and Sclerotherapy with Adjunctive Stasis of Efflux.
Palo N; Chauhan VS; Lakhanpal M; Dey PC; Malik C
J Orthop Case Rep; 2023 Jul; 13(7):110-115. PubMed ID: 37521391
[TBL] [Abstract][Full Text] [Related]
44. Current concepts in diagnosis and treatment of venous malformations.
Judith N; Ulrike E; Siegmar R; Matthias N; Jürgen H
J Craniomaxillofac Surg; 2014 Oct; 42(7):1300-4. PubMed ID: 24969765
[TBL] [Abstract][Full Text] [Related]
45. [Interdisciplinary concept for classification and treatment of vascular anomalies in the head and neck].
Ernemann U; Hoffmann J; Breuninger H; Reinert S; Skalej M
Mund Kiefer Gesichtschir; 2002 Nov; 6(6):402-9. PubMed ID: 12447652
[TBL] [Abstract][Full Text] [Related]
46. Total clinical regression of an orbital macrocystic lymphatic malformation following intralesional sodium tetradecyl sulphate injection.
Kiratli H; Tarlan B
J AAPOS; 2015 Feb; 19(1):78-80. PubMed ID: 25727595
[TBL] [Abstract][Full Text] [Related]
47. Percutaneous drainage and ablation as first line therapy for macrocystic and microcystic orbital lymphatic malformations.
Hill RH; Shiels WE; Foster JA; Czyz CN; Stacey A; Everman KR; Cahill KV
Ophthalmic Plast Reconstr Surg; 2012; 28(2):119-25. PubMed ID: 22366666
[TBL] [Abstract][Full Text] [Related]
48. Combined Nd:YAG laser and bleomycin sclerotherapy under the same anesthesia for cervicofacial venous malformations: A safe and effective treatment option.
Gregory S; Burrows PE; Ellinas H; Stadler M; Chun RH
Int J Pediatr Otorhinolaryngol; 2018 May; 108():30-34. PubMed ID: 29605361
[TBL] [Abstract][Full Text] [Related]
49. Treatment of unusual vascular lesions: usefulness of sclerotherapy in lymphangioma circumscriptum and acquired digital arteriovenous malformation.
Park CO; Lee MJ; Chung KY
Dermatol Surg; 2005 Nov; 31(11 Pt 1):1451-3. PubMed ID: 16416619
[TBL] [Abstract][Full Text] [Related]
50. Percutaneous sclerotherapy with ethanolamine oleate for lymphatic malformations of the head and neck.
Alexander MD; McTaggart RA; Choudhri OA; Marcellus ML; Do HM
J Neurointerv Surg; 2014 Nov; 6(9):691-4. PubMed ID: 24153336
[TBL] [Abstract][Full Text] [Related]
51. Vascular Anomalies: A Pediatric Surgeon's Perspective.
Gupta A; Verma A; Dhua A; Bhatnagar V
Indian J Pediatr; 2017 Aug; 84(8):612-617. PubMed ID: 28466404
[TBL] [Abstract][Full Text] [Related]
52. Coagulation abnormalities in pediatric and adult patients after sclerotherapy or embolization of vascular anomalies.
Mason KP; Neufeld EJ; Karian VE; Zurakowski D; Koka BV; Burrows PE
AJR Am J Roentgenol; 2001 Dec; 177(6):1359-63. PubMed ID: 11717083
[TBL] [Abstract][Full Text] [Related]
53. Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience.
Tan KT; Kirby J; Rajan DK; Hayeems E; Beecroft JR; Simons ME
J Vasc Interv Radiol; 2007 Mar; 18(3):343-51. PubMed ID: 17377179
[TBL] [Abstract][Full Text] [Related]
54. Percutaneous sclerotherapy with ethanolamine oleate for venous malformations of the head and neck.
Alexander MD; McTaggart RA; Choudhri OA; Marcellus ML; Do HM
J Neurointerv Surg; 2014 Nov; 6(9):695-8. PubMed ID: 24235099
[TBL] [Abstract][Full Text] [Related]
55. Sclerotherapy for intramuscular vascular malformations: A single-center experience.
Scorletti F; Patel MN; Hammill AM; Ricci KW; Myer CM; Dasgupta R
J Pediatr Surg; 2018 May; 53(5):1056-1059. PubMed ID: 29519571
[TBL] [Abstract][Full Text] [Related]
56. Sclerotherapy for eyelid and anterior orbital venous-lymphatic malformation.
Razavi ME; Rajabi MT; Hassanpoor N; Mohammadi SS
J Curr Ophthalmol; 2019 Jun; 31(2):214-217. PubMed ID: 31317102
[TBL] [Abstract][Full Text] [Related]
57. Sclerotherapy of Diffuse and Infiltrative Venous Malformations of the Hand and Distal Forearm.
Guevara CJ; Gonzalez-Araiza G; Kim SK; Sheybani E; Darcy MD
Cardiovasc Intervent Radiol; 2016 May; 39(5):705-710. PubMed ID: 26678548
[TBL] [Abstract][Full Text] [Related]
58. Use of percutaneous foam sclerotherapy with 1.5% sodium tetradecyl sulfate for treatment of a pelvic limb venous malformation in a dog.
Chang S; Weisse C; Berent AC; Rosen RJ
J Am Vet Med Assoc; 2020 Jun; 256(12):1368-1374. PubMed ID: 32459582
[TBL] [Abstract][Full Text] [Related]
59. Complications After Treatment of Head and Neck Venous Malformations With Sodium Tetradecyl Sulfate Foam.
Colletti G; Deganello A; Bardazzi A; Mattassi R; Dalmonte P; Gazzabin L; Stillo F
J Craniofac Surg; 2017 Jun; 28(4):e388-e392. PubMed ID: 28328612
[TBL] [Abstract][Full Text] [Related]
60. Paradoxical embolism following intralesional sclerotherapy for cervical venous malformation.
Allevi F; Rabbiosi D; Mandalà M; Colletti G
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25422340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
